Scoring System Stratifies Risk of Heart Failure in Patients With Acute Leukemia
May 18th 2020Baseline clinical characteristics coupled with measurable cardiac parameters can be used to predict the risk of heart failure among adults with acute leukemia who receive anthracycline-based therapy, according to recent study findings.
Chasing a Cure for GBM: Investigators Test Multiple Regimens in Novel Trial
May 14th 2020Investigators of the first global adaptive phase 2/3 GBM Adaptive Global Innovative Learning Environment platform trial are implementing a multiarm, 2-stage approach to concurrently evaluate single-agent and combination regimens in glioblastoma.
Looking Forward to a New Wave of Breast Cancer Therapies
May 14th 2020The degree to which nature and nurture affect disease has long been debated in medicine, and it is an issue that esteemed breast cancer researcher and medical oncologist Joyce A. O’Shaughnessy, MD, has been working to unravel for her patients throughout a career that spans more than 30 years.
OncLive Insights®: Chemotherapy Findings Help Clarify Sequencing Options in mCRPC
May 13th 2020Although numerous therapies have been introduced for patients with metastatic castration-resistant prostate cancer, the question of how to optimally sequence treatments for those who experience progression remains a vexing clinical challenge.
Robot-Assisted Cystectomy Is Feasible for Many Patients With Bladder Cancer
May 11th 2020To determine the 10-year oncologic outcomes and recurrence patterns after robot-assisted radical cystectomy, a group within the Department of Urology at Roswell Park Comprehensive Cancer Center performed a retrospective review.
Oncology Clinical Trials Should Reflect Molecular Advances, Real-World Patients
May 11th 2020From the earliest moments of medical school instruction, through residency and fellowship training, physicians are taught the primacy of the randomized phase 3 trial in the hierarchy of evidence-based medicine.